NephroPlus
NephroPlus operates Asia's largest dialysis care network with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia, serving 33,000+ patients annually via in-clinic, home, holiday, and mobile dialysis modalities backed by proprietary clinical technology.
- Company typePublic
- Founded2009
- HeadquartersHyderabad, India
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What NephroPlus does
NephroPlus operates Asia's largest dialysis care network, with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia serving over 33,000 patients annually. Founded in 2009 and headquartered in Hyderabad, the company delivered 3.84 million dialysis treatments in FY26 across service modalities including In-Clinic Dialysis, Dialysis on Call (hospital bedside), Home Hemodialysis, Holiday Dialysis (cross-border travel), and Dialysis on Wheels (mobile units). The clinical operation is underpinned by proprietary technology such as the Renova automated dialyzer reprocessing system and an AI-enabled remote monitoring platform that tracks 28 clinical parameters per session, deployed initially within the Karnataka public-private partnership program.
The revenue model is anchored in per-treatment fees from a mix of individual patients, government PPP contracts (notably the Karnataka state program), and corporate insurance / TPA channels. International operations contributed 42% of FY26 revenue, reflecting a deliberate multi-country expansion funded in part by a Rs 69.5 crore Asian Development Bank loan for the Uzbekistan buildout and a series of Philippines acquisitions. NephroPlus holds NABH and ISO 27001 accreditations and runs the NephroPlus Academy, which has trained over 1,000 clinical staff over nine years.
The company completed an IPO in December 2025, raising Rs 871 crore earmarked for 167 new clinics and pre-payment of debt. Pre-IPO investors Quadria Capital (~30% retained) and Bessemer Venture Partners have backed both organic growth and inorganic expansion through Renal Therapy Solutions Inc. (Feb 2024), seven additional Philippines clinics (Feb 2025), and Amica Healthcare System dialysis assets (June 2026). FY26 revenue of Rs 998.8 crore grew 32.2% year-over-year with adjusted consolidated net profit up 74.6%, and management has guided to 15-20% revenue CAGR over the next 3-4 years.
NephroPlus firmographics
Firmographics- Name
- NephroPlus
- Legal name
- Nephrocare Health Services Limited
- Website
- https://nephroplus.com
- Company type
- Public
- Founded year
- 2009
- Operating status
- Ipo
- Headcount range
- 1,001–5,000 employees
- Short description
- NephroPlus operates Asia's largest dialysis care network with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia, serving 33,000+ patients annually via in-clinic, home, holiday, and mobile dialysis modalities backed by proprietary clinical technology.
- Ownership category
- akta.pro rank
NephroPlus industry classification
Industry- Product category
- Dialysis Care Services
- NAICS
- Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621), Home Health Equipment Rental (532283)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)
- akta.pro secondary industries
- Home Dialysis Programs (Home HD/PD Training & Support) (HLAKAHAK), Outpatient Dialysis & Kidney Care Centers (HLAFABAE), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Home Dialysis Support & Training Providers (HLAFAEAG)
Keywords
Where NephroPlus is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
NephroPlus business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Dialysis Treatment Services: Revenue from providing dialysis treatments to patients across 520+ centers in India and internationally. Revenue grew 32.2% to Rs 998.8 crore in FY26 with 38.4 lakh treatments performed.
- Public-Private Partnership (PPP) Programs: Government partnerships such as the Karnataka PPP dialysis programme where the company provides dialysis services in government hospitals.
- Home and Specialty Dialysis Services: Premium services including Home Hemodialysis, Dialysis on Wheels, Dialysis on Call, and Holiday Dialysis programs for travelers.
- Training and Academy Services: NephroPlus Academy provides dialysis technician and nursing training with placement services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | In-Clinic Dialysis - Standard dialysis treatment at NephroPlus centers |
| Other | Monthly | Home Hemodialysis - Dialysis treatment at patient's home |
| Other | Pay-as-you-go | Holiday Dialysis - Dialysis services at tourist destinations |
| Other | Pay-as-you-go | Dialysis on Wheels - Mobile dialysis van service |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels7 records
NephroPlus product offering
Product offeringCore offering
NephroPlus operates a multi-modal dialysis care network providing in-clinic dialysis at 520+ centers across India, Philippines, Uzbekistan, Nepal, and Saudi Arabia. The company also delivers dialysis treatment through home-based setups, mobile vans (Dialysis on Wheels), temporary setups delivered to patient locations (Dialysis on Call), and a holiday dialysis program for traveling patients. It supplements these with digital services including a mobile app, AI-enabled clinical monitoring, and a technician training academy.
Product overview
NephroPlus operates a multi-modal dialysis care platform providing five distinct service delivery models: In-Clinic Dialysis at their network of 500+ state-of-the-art centres, Dialysis on Call (temporary mobile setup delivered to homes/hospitals), Home Hemodialysis (permanent home installation with equipment and staff), Holiday Dialysis (travel-compatible treatment), and Dialysis on Wheels (mobile van service). The company complements its core dialysis services with a digital ecosystem comprising a mobile app for appointment management, an AI-enabled monitoring system for clinical quality assurance, a Kidney Health Assessment tool, and diet/nutrition support. NephroPlus also operates a Dialysis Academy for technician training and runs patient engagement programmes including the Dialysis Olympiad and Aashayein events.
Differentiator
Problem solved
Functional benefit
Brands
- Dialysis on Wheels: Mobile dialysis van service for patients needing on-site care
- Dialysis on Call
- Home Hemodialysis
- Holiday Dialysis
- Renova
- NephroPlus Academy
Products and services
- In-Clinic Dialysis Standard hemodialysis treatment delivered at NephroPlus's 500+ state-of-the-art centers across India, equipped with modern machines, strict hygiene protocols, qualified technicians, in-house entertainment, and patient comfort amenities. Targeted at chronic kidney disease patients requiring regular dialysis.
- Home Hemodialysis Permanent home-based dialysis setup including a hemodialysis machine, water treatment plant, and regular clinical staff monitoring, enabling patients to undergo treatment in the comfort of their homes with reduced infection risk and scheduling flexibility.
- Dialysis on Wheels Mobile dialysis van service delivering full in-clinic quality dialysis treatment to patients' doorsteps or workplaces, featuring a fully operational ambulance setup with dialysis machine, RO plant, recliner or bed, and trained staff.
- Dialysis on Call Mobile dialysis service that delivers a complete dialysis setup to the patient's home or hospital location, conducts the procedure, and then removes the equipment, providing temporary dialysis capability without permanent installation.
- Holiday Dialysis Dialysis service enabling patients to travel while continuing treatment, with NephroPlus managing travel, accommodation, and treatment logistics at destination clinics across India and internationally.
- NephroPlus Mobile App Mobile application for easier appointment bookings, accessing dialysis-related reads, and managing dialysis needs. Available on iOS and Android platforms.
- NephroPlus Dialysis Academy Training institute for dialysis technician and nursing professionals that has trained and placed over 1,000 students across NephroPlus centres and leading healthcare institutions over 9 years.
Quantifiable outcome
- 32% year-on-year revenue growth to ₹998.8 crore in FY26
- +4 more outcomes
Companies that use NephroPlus
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
NephroPlus technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
NephroPlus partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered strategic and flagship.
- Amica Healthcare System CorporationstrategicAsset Transfer Agreement signed on June 9, 2026 for acquisition of dialysis center assets in Paranaque City, Philippines valued at PhP 32,640,000 (approximately $560,000).
- Karnataka GovernmentflagshipPublic-Private Partnership dialysis programme with Karnataka government where NephroPlus provides AI-enabled monitoring for government dialysis units at KC General Hospital Bengaluru and six other centers.
Scale indicators10 records
Recent moves9 records
Expansion highlights6 records
NephroPlus competitors and assessment
Company assessmentBroad incumbents
- DaVita: Global dialysis services leader with ~3,100 outpatient clinics in the US and international presence including India. Comparable as the dominant global pure-play dialysis network, with significantly larger scale, established PPP/insurance relationships, and proven multi-modality delivery.
- Fresenius Medical Care: World's largest dialysis services and products company, operating ~4,000 clinics globally including India (Fresenius Medical Care India). Comparable on integrated dialysis services plus equipment/dialyzer manufacturing, and a direct competitor for Indian PPP tenders.
- B. Braun Avitum: Division of B. Braun Melsungen providing dialysis services (clinics) and hemodialysis products across Europe, Asia, and Africa. Comparable as an integrated dialysis services and equipment provider with international clinic footprint.
- Apollo Hospitals Enterprise: India's largest hospital chain with extensive nephrology and dialysis programs across 70+ facilities. Comparable as the primary Indian multi-specialty competitor with embedded nephrologist referral pipeline and PPP relationships.
- Fortis Healthcare: Major Indian multi-specialty hospital operator with nephrology and dialysis services across its network. Comparable as a domestic competitor using hospital infrastructure to deliver dialysis and capture CKD patient flow.
- Max Healthcare Institute: Leading North India hospital chain with nephrology and dialysis programs. Comparable as an Indian listed multi-specialty competitor that NephroPlus competes with for nephrologist affiliations and PPP contracts.
Direct peers
- Diaverum: Sweden-based pure-play dialysis network with 450+ clinics across 24 countries, including a strong emerging-market focus (Latin America, Middle East, Asia). Highly comparable as a multi-country dialysis services operator pursuing similar international expansion playbook.
- U.S. Renal Care: US-based dialysis services company operating ~400 in-center and home dialysis clinics. Comparable as a PE-backed (Bain Capital, KKR) multi-state pure-play dialysis services operator with home dialysis emphasis.
- Dialysis Clinic, Inc. (DCI): US non-profit dialysis provider operating 250+ clinics across 30 states. Comparable as a long-established multi-state pure-play dialysis services network, though non-profit status differentiates funding model.
Regional players
- Asiri Hospitals Holdings: Sri Lanka's largest private hospital chain with nephrology and dialysis services. Comparable as a South Asian regional hospital operator that competes for cross-border medical tourism and validates the regional specialty care thesis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks7 records
Key highlights7 records
Customer concentration
NephroPlus social profiles
Digital presenceNephroPlus compliance and trust
Trust signalCompliance3 records
NephroPlus financial estimates
Financial estimateRevenue estimate
Valuation estimate
NephroPlus leadership team
Management profileNumber of profiles
Profiles17 records
NephroPlus subsidiaries and ownership
Company hierarchySubsidiaries3 records
NephroPlus funding detail
Funding detailFunding overview
Funding rounds9 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NephroPlus M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NephroPlus
What does NephroPlus do?
NephroPlus operates a multi-modal dialysis care network providing in-clinic dialysis at 520+ centers across India, Philippines, Uzbekistan, Nepal, and Saudi Arabia. The company also delivers dialysis treatment through home-based setups, mobile vans (Dialysis on Wheels), temporary setups delivered to patient locations (Dialysis on Call), and a holiday dialysis program for traveling patients. It supplements these with digital services including a mobile app, AI-enabled clinical monitoring, and a technician training academy.
Is NephroPlus a public or private company?
NephroPlus is a public company. It is classified as public and is currently ipo.
When was NephroPlus founded?
NephroPlus was founded in 2009. It employs 1,001 to 5,000 people.
Where is NephroPlus based?
NephroPlus is headquartered in Hyderabad, India, in the Asia region.
How does NephroPlus make money?
Four revenue lines are on record. Dialysis Treatment Services are the primary driver. The others are public-Private Partnership (PPP) Programs, home and Specialty Dialysis Services and training and Academy Services.
Who are NephroPlus's main competitors?
Broad incumbents on record are DaVita, Fresenius Medical Care, B. Braun Avitum, Apollo Hospitals Enterprise, Fortis Healthcare and Max Healthcare Institute. Direct peers are Diaverum, U.S. Renal Care and Dialysis Clinic, Inc. (DCI). Asiri Hospitals Holdings is listed as a regional player.
Does NephroPlus have an API?
No public API is recorded for NephroPlus.
What industry is NephroPlus in?
NephroPlus's product category is Dialysis Care Services. Its primary akta.pro industry code is HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis), with a secondary code of HLAKAHAK, Home Dialysis Programs (Home HD/PD Training & Support). Its NAICS code is 621492 and its SIC code is 8011.